Derivative exercise or conversion — not an open-market buy.
Traded Jul 27, 2026 · Filed Jul 28, 2026
Thermo Fisher Scientific's President & COO sold $226K of Thermo Fisher Scientific shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$226,000
Shares × reported transaction price
4 days after results of Jul 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $559.53 on Jul 27, 2026, 28% above its 52-week low and 13% below its high, after an 18% rise over the previous 30 trading days
52-week range $438.34 (May 15, 2026) to $639.45 (Jan 22, 2026), 60% of the way up, from 251 adjusted closes. 30 trading days earlier: $475.66 on Jun 11, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.2% | +5.5% | -5.3% |
| 30 days | +7.9% | +5.5% | +2.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$63K of Thermo Fisher Scientific
Scheduled in advanceCEO sold ~$21K of Thermo Fisher Scientific
Scheduled in advance